Eaton Vance Management Reata Pharmaceuticals Inc Transaction History

Eaton Vance Management

  • $67.5 Billion
  • Q3 2022

A detailed history of Eaton Vance Management transactions in Reata Pharmaceuticals Inc stock. As of the latest transaction made, Eaton Vance Management holds 15,641 shares of RETA stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,641
Previous 15,649 0.05%
Holding current value
$0
Previous $476,000 17.44%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$19.41 - $36.49 $155 - $291
-8 Reduced 0.05%
15,641 $393,000
Q2 2022

Aug 15, 2022
SELL
$20.71 - $36.5 $251,667 - $443,548
-12,152 Reduced 43.71%
15,649 $476,000
Q1 2022

May 16, 2022
BUY
$24.12 - $39.6 $293,106 - $481,219
12,152 Added 77.65%
27,801 $911,000
Q2 2021

Aug 16, 2021
SELL
$78.27 - $151.29 $21,680 - $41,907
-277 Reduced 1.74%
15,649 $2.22 Million
Q1 2021

May 17, 2021
BUY
$94.25 - $132.81 $26,861 - $37,850
285 Added 1.82%
15,926 $1.59 Million
Q4 2020

Feb 12, 2021
SELL
$102.03 - $184.62 $1,836 - $3,323
-18 Reduced 0.11%
15,641 $1.93 Million
Q2 2020

Aug 13, 2020
BUY
$126.3 - $176.56 $2,273 - $3,178
18 Added 0.12%
15,659 $2.44 Million
Q4 2019

Feb 11, 2020
BUY
$74.57 - $217.92 $350,031 - $1.02 Million
4,694 Added 42.88%
15,641 $3.2 Million
Q2 2019

Aug 16, 2019
BUY
$77.72 - $94.35 $850,800 - $1.03 Million
10,947 New
10,947 $1.03 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Eaton Vance Management Portfolio

Follow Eaton Vance Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email